The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world's population has LTBI. The TB germs are dormant (asleep) in the body.
This report aims to provide a comprehensive presentation of the global market for Latent TB Infection Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent TB Infection Testing. This report contains market size and forecasts of Latent TB Infection Testing in global, including the following market information:
Global Latent TB Infection Testing Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Latent TB Infection Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Mantoux Test / Tuberculin Skin Test (TST) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Latent TB Infection Testing include Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC), Pharmstandard (Generium Pharmaceutical), Sanofi S.A./Sanofi Pasteur Ltd., Statens Serum Institut (SSI), Autoimmun Diagnostika (AID) GmbH, Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., Haikou VTI Biological Institute (Vaccine Technologies, Inc.), Immunoshop India Pvt. Ltd. and Qiagen N.V., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Latent TB Infection Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Latent TB Infection Testing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Latent TB Infection Testing Market Segment Percentages, by Type, 2022 (%)
Mantoux Test / Tuberculin Skin Test (TST)
Interferon-Gamma Release Assay (IGRA)
Global Latent TB Infection Testing Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Latent TB Infection Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Public and Student Health
Physician Offices and Clinics
Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
Global Latent TB Infection Testing Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Latent TB Infection Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Latent TB Infection Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Latent TB Infection Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
Pharmstandard (Generium Pharmaceutical)
Sanofi S.A./Sanofi Pasteur Ltd.
Statens Serum Institut (SSI)
Autoimmun Diagnostika (AID) GmbH
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
Immunoshop India Pvt. Ltd.
Qiagen N.V.
Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
SD Biosensor, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Latent TB Infection Testing, market overview.
Chapter 2: Global Latent TB Infection Testing market size in revenue.
Chapter 3: Detailed analysis of Latent TB Infection Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Latent TB Infection Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Latent TB Infection Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Latent TB Infection Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Latent TB Infection Testing Overall Market Size
2.1 Global Latent TB Infection Testing Market Size: 2022 VS 2030
2.2 Global Latent TB Infection Testing Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Latent TB Infection Testing Players in Global Market
3.2 Top Global Latent TB Infection Testing Companies Ranked by Revenue
3.3 Global Latent TB Infection Testing Revenue by Companies
3.4 Top 3 and Top 5 Latent TB Infection Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Latent TB Infection Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Latent TB Infection Testing Players in Global Market
3.6.1 List of Global Tier 1 Latent TB Infection Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Latent TB Infection Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Latent TB Infection Testing Market Size Markets, 2022 & 2030
4.1.2 Mantoux Test / Tuberculin Skin Test (TST)
4.1.3 Interferon-Gamma Release Assay (IGRA)
4.2 By Type - Global Latent TB Infection Testing Revenue & Forecasts
4.2.1 By Type - Global Latent TB Infection Testing Revenue, 2018-2023
4.2.2 By Type - Global Latent TB Infection Testing Revenue, 2024-2030
4.2.3 By Type - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Latent TB Infection Testing Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Public and Student Health
5.1.4 Physician Offices and Clinics
5.1.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
5.2 By Application - Global Latent TB Infection Testing Revenue & Forecasts
5.2.1 By Application - Global Latent TB Infection Testing Revenue, 2018-2023
5.2.2 By Application - Global Latent TB Infection Testing Revenue, 2024-2030
5.2.3 By Application - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Latent TB Infection Testing Market Size, 2022 & 2030
6.2 By Region - Global Latent TB Infection Testing Revenue & Forecasts
6.2.1 By Region - Global Latent TB Infection Testing Revenue, 2018-2023
6.2.2 By Region - Global Latent TB Infection Testing Revenue, 2024-2030
6.2.3 By Region - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Latent TB Infection Testing Revenue, 2018-2030
6.3.2 US Latent TB Infection Testing Market Size, 2018-2030
6.3.3 Canada Latent TB Infection Testing Market Size, 2018-2030
6.3.4 Mexico Latent TB Infection Testing Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Latent TB Infection Testing Revenue, 2018-2030
6.4.2 Germany Latent TB Infection Testing Market Size, 2018-2030
6.4.3 France Latent TB Infection Testing Market Size, 2018-2030
6.4.4 U.K. Latent TB Infection Testing Market Size, 2018-2030
6.4.5 Italy Latent TB Infection Testing Market Size, 2018-2030
6.4.6 Russia Latent TB Infection Testing Market Size, 2018-2030
6.4.7 Nordic Countries Latent TB Infection Testing Market Size, 2018-2030
6.4.8 Benelux Latent TB Infection Testing Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Latent TB Infection Testing Revenue, 2018-2030
6.5.2 China Latent TB Infection Testing Market Size, 2018-2030
6.5.3 Japan Latent TB Infection Testing Market Size, 2018-2030
6.5.4 South Korea Latent TB Infection Testing Market Size, 2018-2030
6.5.5 Southeast Asia Latent TB Infection Testing Market Size, 2018-2030
6.5.6 India Latent TB Infection Testing Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Latent TB Infection Testing Revenue, 2018-2030
6.6.2 Brazil Latent TB Infection Testing Market Size, 2018-2030
6.6.3 Argentina Latent TB Infection Testing Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Latent TB Infection Testing Revenue, 2018-2030
6.7.2 Turkey Latent TB Infection Testing Market Size, 2018-2030
6.7.3 Israel Latent TB Infection Testing Market Size, 2018-2030
6.7.4 Saudi Arabia Latent TB Infection Testing Market Size, 2018-2030
6.7.5 UAE Latent TB Infection Testing Market Size, 2018-2030
7 Latent TB Infection Testing Companies Profiles
7.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
7.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Summary
7.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
7.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Major Product Offerings
7.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Key News & Latest Developments
7.2 Pharmstandard (Generium Pharmaceutical)
7.2.1 Pharmstandard (Generium Pharmaceutical) Company Summary
7.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
7.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Major Product Offerings
7.2.4 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.2.5 Pharmstandard (Generium Pharmaceutical) Key News & Latest Developments
7.3 Sanofi S.A./Sanofi Pasteur Ltd.
7.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Summary
7.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
7.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Major Product Offerings
7.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Key News & Latest Developments
7.4 Statens Serum Institut (SSI)
7.4.1 Statens Serum Institut (SSI) Company Summary
7.4.2 Statens Serum Institut (SSI) Business Overview
7.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Major Product Offerings
7.4.4 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.4.5 Statens Serum Institut (SSI) Key News & Latest Developments
7.5 Autoimmun Diagnostika (AID) GmbH
7.5.1 Autoimmun Diagnostika (AID) GmbH Company Summary
7.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
7.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Major Product Offerings
7.5.4 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.5.5 Autoimmun Diagnostika (AID) GmbH Key News & Latest Developments
7.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
7.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Summary
7.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
7.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Major Product Offerings
7.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Key News & Latest Developments
7.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
7.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Summary
7.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
7.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Major Product Offerings
7.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Key News & Latest Developments
7.8 Immunoshop India Pvt. Ltd.
7.8.1 Immunoshop India Pvt. Ltd. Company Summary
7.8.2 Immunoshop India Pvt. Ltd. Business Overview
7.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Major Product Offerings
7.8.4 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.8.5 Immunoshop India Pvt. Ltd. Key News & Latest Developments
7.9 Qiagen N.V.
7.9.1 Qiagen N.V. Company Summary
7.9.2 Qiagen N.V. Business Overview
7.9.3 Qiagen N.V. Latent TB Infection Testing Major Product Offerings
7.9.4 Qiagen N.V. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.9.5 Qiagen N.V. Key News & Latest Developments
7.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
7.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Summary
7.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
7.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Major Product Offerings
7.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Key News & Latest Developments
7.11 SD Biosensor, Inc.
7.11.1 SD Biosensor, Inc. Company Summary
7.11.2 SD Biosensor, Inc. Business Overview
7.11.3 SD Biosensor, Inc. Latent TB Infection Testing Major Product Offerings
7.11.4 SD Biosensor, Inc. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.11.5 SD Biosensor, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Latent TB Infection Testing Market Opportunities & Trends in Global Market
Table 2. Latent TB Infection Testing Market Drivers in Global Market
Table 3. Latent TB Infection Testing Market Restraints in Global Market
Table 4. Key Players of Latent TB Infection Testing in Global Market
Table 5. Top Latent TB Infection Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Latent TB Infection Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Latent TB Infection Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Latent TB Infection Testing Product Type
Table 9. List of Global Tier 1 Latent TB Infection Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Latent TB Infection Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Latent TB Infection Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Latent TB Infection Testing Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Latent TB Infection Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Latent TB Infection Testing Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Latent TB Infection Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Latent TB Infection Testing Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 30. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Summary
Table 31. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offerings
Table 32. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Key News & Latest Developments
Table 34. Pharmstandard (Generium Pharmaceutical) Company Summary
Table 35. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offerings
Table 36. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Pharmstandard (Generium Pharmaceutical) Key News & Latest Developments
Table 38. Sanofi S.A./Sanofi Pasteur Ltd. Company Summary
Table 39. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offerings
Table 40. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi S.A./Sanofi Pasteur Ltd. Key News & Latest Developments
Table 42. Statens Serum Institut (SSI) Company Summary
Table 43. Statens Serum Institut (SSI) Latent TB Infection Testing Product Offerings
Table 44. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Statens Serum Institut (SSI) Key News & Latest Developments
Table 46. Autoimmun Diagnostika (AID) GmbH Company Summary
Table 47. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offerings
Table 48. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Autoimmun Diagnostika (AID) GmbH Key News & Latest Developments
Table 50. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Summary
Table 51. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offerings
Table 52. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Key News & Latest Developments
Table 54. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Summary
Table 55. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offerings
Table 56. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Key News & Latest Developments
Table 58. Immunoshop India Pvt. Ltd. Company Summary
Table 59. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offerings
Table 60. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Immunoshop India Pvt. Ltd. Key News & Latest Developments
Table 62. Qiagen N.V. Company Summary
Table 63. Qiagen N.V. Latent TB Infection Testing Product Offerings
Table 64. Qiagen N.V. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Qiagen N.V. Key News & Latest Developments
Table 66. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Summary
Table 67. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offerings
Table 68. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Key News & Latest Developments
Table 70. SD Biosensor, Inc. Company Summary
Table 71. SD Biosensor, Inc. Latent TB Infection Testing Product Offerings
Table 72. SD Biosensor, Inc. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 73. SD Biosensor, Inc. Key News & Latest Developments
List of Figures
Figure 1. Latent TB Infection Testing Segment by Type in 2022
Figure 2. Latent TB Infection Testing Segment by Application in 2022
Figure 3. Global Latent TB Infection Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Latent TB Infection Testing Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Latent TB Infection Testing Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Latent TB Infection Testing Revenue in 2022
Figure 8. By Type - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 9. By Application - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 10. By Type - Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 12. By Application - Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 14. By Region - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 15. By Country - North America Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 16. US Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 20. Germany Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 21. France Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 28. China Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 32. India Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 34. Brazil Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 37. Turkey Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 41. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Qiagen N.V. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. SD Biosensor, Inc. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
